Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD
Show Description +
What are the real-world safety data following administration of faricimab (Vabysmo, Genentech)? Maura Di Nicola, MD, and guests Sruthi Arepalli, MD, and Barton Blackorby, MD, review data from a real-world, single-center, retrospective study of approximately 4500 injections of faricimab in over 700 patients at Wills Eye Hospital. What did the data show? And do these data effect the clinical patterns of Drs. Di Nicola, Arepalli, and Blackorby? This editorially independent episode of New Retina Radio is Sponsored by Apellis.
Posted: 3/20/2025
Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD
What are the real-world safety data following administration of faricimab (Vabysmo, Genentech)? Maura Di Nicola, MD, and guests Sruthi Arepalli, MD, and Barton Blackorby, MD, review data from a real-world, single-center, retrospective study of approximately 4500 injections of faricimab in over 700 patients at Wills Eye Hospital. What did the data show? And do these data effect the clinical patterns of Drs. Di Nicola, Arepalli, and Blackorby? This editorially independent episode of New Retina Radio is Sponsored by Apellis.
Posted: 3/20/2025
New Retina Radio is forging forward with education, and they’re partnering with Vit Buckle Society to make it happen. Check out these quick-hit reviews of journal articles delivered by VBS members.
Rates of Ocular AEs After Faricimab Injection
Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD
Please log in to leave a comment.